486 results on '"Ottesen, Eric"'
Search Results
2. A refined and updated health impact assessment of the Global Programme to Eliminate Lymphatic Filariasis (2000–2020)
3. U1 snRNA interactions with deep intronic sequences regulate splicing of multiple exons of spinal muscular atrophy genes.
4. Transcriptome- and proteome-wide effects of a circular RNA encompassing four early exons of the spinal muscular atrophy genes
5. Synergistic Effect of an Antisense Oligonucleotide and Small Molecule on Splicing Correction of the Spinal Muscular Atrophy Gene
6. A super minigene with a short promoter and truncated introns recapitulates essential features of transcription and splicing regulation of the SMN1 and SMN2 genes.
7. Optimized strategy for real-time qPCR detection of Onchocerca volvulus DNA in pooled Simulium sp. blackfly vectors
8. Control and elimination of lymphatic filariasis in Oceania: Prevalence, geographical distribution, mass drug administration, and surveillance in Samoa, 1998–2017
9. Diverse targets of SMN2-directed splicing-modulating small molecule therapeutics for spinal muscular atrophy
10. Gender-Specific Amelioration of SMA Phenotype upon Disruption of a Deep Intronic Structure by an Oligonucleotide
11. The design and development of a multicentric protocol to investigate the impact of adjunctive doxycycline on the management of peripheral lymphoedema caused by lymphatic filariasis and podoconiosis
12. Filariasis and Erisipela in Santo Domingo
13. ISS-N1 makes the first FDA-approved drug for spinal muscular atrophy
14. Elimination of lymphatic filariasis as a public health problem from the Cook Islands
15. The Neglected Tropical Diseases: The Ancient Afflictions of Stigma and Poverty and the Prospects for their Control and Elimination
16. Towards Accelerating Tool Development for Global Health
17. Heritable Factors Play a Major Role in Determining Host Responses to Wuchereria bancrofti Infection in an Isolated South Pacific Island Population
18. Filariasis: Present Status and Future Challenges
19. Bacterial Endosymbionts of Onchocerca volvulus in the Pathogenesis of Posttreatment Reactions
20. High Concentration of an ISS-N1-Targeting Antisense Oligonucleotide Causes Massive Perturbation of the Transcriptome
21. Evolution of Immunologic Responsiveness of Persons Living in an Area of Endemic Bancroftian Filariasis: A 17-Year Follow-up
22. Chapter Two - Control and elimination of lymphatic filariasis in Oceania: Prevalence, geographical distribution, mass drug administration, and surveillance in Samoa, 1998–2017
23. Eosinophil Sequestration and Activation Are Associated with the Onset and Severity of Systemic Adverse Reactions following the Treatment of Onchocerciasis with Ivermectin
24. Efficacy of Diethylcarbamazine in Eradicating Infection with Lymphatic-Dwelling Filariae in Humans
25. Immediate Hypersensitivity Responses in the Immunopathogenesis of Human Onchocerciasis
26. Antisense Methods to Modulate Pre-mRNA Splicing
27. Baseline Mapping of Neglected Tropical Diseases in Africa: The Accelerated WHO/AFRO Mapping Project
28. Evidence for Protective Immunity to Bancroftian Filariasis in the Cook Islands
29. Evaluation of a Polymerase Chain Reaction-Based Assay for Diagnosis of Wuchereria bancrofti Infection
30. Elevations in Granulocyte-Macrophage Colony-Stimulating Factor and Interleukin-5 Levels Precede Posttreatment Eosinophilia in Onchocerciasis
31. High Levels of Spontaneous and Parasite Antigen-Driven Interleukin-10 Production Are Associated with Antigen-Specific Hyporesponsiveness in Human Lymphatic Filariasis
32. Corrigendum to: Medicine donation programmes supporting the global drive to end the burden of neglected tropical diseases
33. Medicine donation programmes supporting the global drive to end the burden of neglected tropical diseases
34. Additional file 4 of The design and development of a multicentric protocol to investigate the impact of adjunctive doxycycline on the management of peripheral lymphoedema caused by lymphatic filariasis and podoconiosis
35. Additional file 1 of The design and development of a multicentric protocol to investigate the impact of adjunctive doxycycline on the management of peripheral lymphoedema caused by lymphatic filariasis and podoconiosis
36. Additional file 3 of The design and development of a multicentric protocol to investigate the impact of adjunctive doxycycline on the management of peripheral lymphoedema caused by lymphatic filariasis and podoconiosis
37. Additional file 2 of The design and development of a multicentric protocol to investigate the impact of adjunctive doxycycline on the management of peripheral lymphoedema caused by lymphatic filariasis and podoconiosis
38. Incorporating a rapid-impact package for neglected tropical diseases with programs for HIV/AIDS, tuberculosis, and malaria: a comprehensive pro-poor health policy and strategy for the developing world
39. Evolution of the monitoring and evaluation strategies to support the World Health Organization's Global Programme to Eliminate Lymphatic Filariasis
40. Setting the stage for a Global Programme to Eliminate Lymphatic Filariasis: the first 125 years (1875–2000)
41. Towards a comprehensive research and development plan to support the control, elimination and eradication of neglected tropical diseases
42. An intronic structure enabled by a long-distance interaction serves as a novel target for splicing correction in spinal muscular atrophy
43. Group Report: Assessing the Feasibility of an Eradication Initiative
44. Contributors
45. Filariasis
46. Projected benefits from integrating NTD programs in sub-Saharan Africa
47. Characteristics of circular RNAs generated by human Survival Motor Neuron genes
48. A survey of transcripts generated by spinal muscular atrophy genes
49. The First Orally Deliverable Small Molecule for the Treatment of Spinal Muscular Atrophy
50. Description, Mechanisms and Control of Reactions to Treatment in the Human Filariases
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.